Basic amino acids at the C-terminus of the third intracellular loop are required for the activation of phospholipase C by cholecystokinin-B receptors

Journal of Neurochemistry

Volumn 68, Issue 4, 1997, Pages 1728-1735

  Wang, Hung Li ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Ca2+ activated Cl currents; Cholecystokinin B receptors; G(q) proteins; Inositol phosphates; Phospholipase C; Sulfated cholecystokinin octapeptide

Indexed keywords

AMINO ACID; CALCIUM; CHOLECYSTOKININ OCTAPEPTIDE; CHOLECYSTOKININ RECEPTOR; INOSITOL PHOSPHATE; PHOSPHOLIPASE C;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHLORIDE CURRENT; ENZYME ACTIVATION; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; XENOPUS;

ANIMALIA;

EID: 0030943262     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.68041728.x     Document Type: Article

References (48)

1. Arai H., Hori S., Ohkubo H., and Nakanishi S. (1990) Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348, 730-732.
2. Benya R. V., Akeson M., Mrozinski J., Jensen R., and Battey J. F. (1994) Internalization of the gastrin-releasing peptide receptor is mediated by both phospholipase C-dependent and -independent processes. Mol. Pharmacol. 46, 495-501.
3. Berridge M. J. (1993) Inositol trisphosphate and calcium signaling. Nature 361, 315-323.
4. Bluml K., Mutschler E., and Wess J. (1994) Insertion mutagenesis as a tool to predict the secondary structure of a muscarinic receptor domain determining specificity of G-protein coupling. Proc. Natl. Acad. Sci. USA 91, 7980-7984.
5. Burstein E. S., Spalding T. A., Hill-Eubanks D., and Brann M. R. (1995) Structure-function of muscarinic receptor coupling to G proteins: random saturation mutagenesis identifies a critical determinant of receptor affinity for G proteins. J. Biol. Chem. 270, 3141-3146.
6. Chang R. S. L. and Lotti V. J. (1991) Ligands for cholecystokinin A and cholecystokinin B/gastrin receptors, in Methods in Neuroscience, Vol. 5 (Conn M., ed), pp. 479-493. Academic Press, San Diego.
7. 1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological functions. Proc. Natl. Acad. Sci. USA 87, 2896-2900.
8. Crawley J. N. (1985) Comparative distribution of cholecystokinin and other neuropeptides. Ann. NY Acad. Sci. 448, 1-8.
9. Cullen B. R. (1987) Use of eukaryotic expression technology in the functional analysis of cloned genes. Methods Enzymol. 152, 684-704.
10. 2A-adrenergic receptor alter receptor-G protein coupling by distinct mechanisms. J. Biol. Chem. 266, 11025-11029.
11. Emson P. C., Rchfeld J. F., and Rossor M. N. (1982) Distribution of cholecystokinin-like peptides in the human brain. J. Neurochem. 38, 1177-1185.
12. Godfrey P. P. (1992) Methods for the analysis of phosphoinositides and inositol phosphates, in Intracellular Messengers, Neuromethods, Vol. 20 (Boulton A., Baker G., and Taylor C., eds), pp. 57-78. Humana Press, Totowa, New Jersey.
13. Hawes B. E., Luttrell L. M., Exum S. T., and Lefkowitz R. J. (1994) Inhibition of G protein-coupled receptor signaling by expression of cytoplasmic domains of the receptor. J. Biol. Chem. 269, 15776-15785.
14. Helper J. R. and Gilman A. G. (1992) G proteins. Trends Biochem. Sci. 17, 383-387.
15. o by mastoparan, related amphiphilic peptides, and hydrophobic amines. J. Biol. Chem. 265, 14176-14186.
16. Hogger P., Shockley M. S., Lameh J., and Sadee W. (1995) Activating and inactivating mutations in N- and C-terminal i-3 loop junctions of muscarinic acetylcholine Hm1 receptors. J. Biol. Chem. 270, 7405-7410.
17. Hughes J., Boden P., Costall B., Domeney A., Kelly E., Horwell D. C., Hunter J. C., Pinnock R. D., and Woodruff G. N. (1990) Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity. Proc. Natl. Acad. Sci. USA 87, 6728-6733.
18. Ito W., Ishiguro H., and Kurosawa Y. (1991) A general method for introducing a series of mutations into cloned DNA using the polymerase chain reaction. Gene 102, 67-70.
19. 100 in the second transmembrane domain of the cholecystokinin B receptor increases antagonist binding and reduces signal transduction. Mol. Pharmacol. 48, 783-789.
20. Kobilka B. (1992) Adrenergic receptors as models for G protein-coupled receptors. Annu. Rev. Neurosci. 15, 87-114.
21. Kopin A. S., Lee Y. M., McBride E. W., Miller L. J., Lu M., Lin H. Y., Kolakowski L. F., and Beinborn M. (1992) Expression cloning and characterization of the canine parietal cell gastrin receptor. Proc. Natl. Acad. Sci. USA 89, 3605-3609.
22. Kunkel M. T. and Peralta E. G. (1993) Charged amino acids required for signal transduction by the m3 muscarinic acetylcholine receptor. EMBO J. 12, 3809-3815.
23. Lechleiter J., Hellmiss R., Duerson K., Ennulat D., David N., Clapham D., and Peralta E. (1990) Distinct sequence elements control the specificity of G protein by muscarinic acetylcholine receptor subtypes. EMBO J. 9, 4381-4390.
24. Lee N. H., Geoghagen N. S. M., Cheng E., Cline R. T., and Fraser C. M. (1996) Alanine scanning mutagenesis of conserved arginine/lysine-arginine/lysine-X-X-arginine/lysine G protein-activating motifs on m1 muscarinic acetylcholine receptors. Mol Pharmacol. 50, 140-148.
25. Lee Y. M., Beinborn M., McBride E. W., Lu M., Kolakowski L. F., and Kopin A. S. (1993) The human brain cholecystokinin-B/ gastrin receptor. J. Biol. Chem. 268, 8164-8172.
26. Moran T. H. and McHugh P. (1990) Cholecystokinin receptors, in Handbook of Chemical Neuroanatomy, Vol. 9 (Bjorklund A., Hokfelt T., and Kuhar M. J., eds), pp. 455-475. Elsevier, Amsterdam.
27. 2-adrenergic receptor. J. Biol. Chem. 263, 15985-15992.
28. 2-adrenergic receptors based upon characteristics in primary structure. J. Biol. Chem. 267, 8342-8346.
29. Okamoto T., Katada T., Murayama Y., Ui M., Ogata E., and Nishimoto I. (1990) A simple structure encodes G protein-activating function of the IGF-II/mannose6-phosphate receptor. Cell 62, 709-717.
30. 2+. J. Physiol. (Lond.) 408, 223-232.
31. 0α by peptides representing sequence permutations of mastoparan. Proc. Natl. Acad. Sci. USA 89, 8268-8272.
32. 2-adrenergic receptor: how structure elucidates function. Annu. Rev. Pharmacol. 32, 167-183.
33. Rehfeld J. F., Hansen H. F., Marley P. D., and Stengaard-Pedersen K. (1985) Molecular forms of cholecystokinin in the brain and relationship to neuronal gastrins. Ann. NY Acad. Sci. 448, 11-20.
34. Savarese T. M. and Fraser C. M. (1992) In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors. Biochem. J. 283, 1-19.
35. Sigel E. (1990) Use of Xenopus oocytes for the functional expression of plasma membrane proteins. J. Membr. Biol. 117, 201-221.
36. Strader C. D., Fong T. M., Michael R. T., Underwood D., and Dixon R. A. F. (1994) Structure and function of G protein-coupled receptors. Annu. Rev. Biochem. 63, 101-132.
37. Sukumar M. and Higashijima T. (1992) G protein-bound conformation of mastoparan-X, a receptor-mimetic peptide. J. Biol. Chem. 267, 21421-21424.
38. 3H-cholecystokinin as radioligand. J. Neurosci. 4, 1021-1031.
39. q coupling by the use of receptor chimeras. J. Biol. Chem. 270, 16677-16682.
40. Wank S. A., Harkins R., Jensen R., Shapira H., de Weerth A., and Slattery T. (1992a) Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas. Proc. Natl. Acad. Sci. USA 89, 3125-3129.
41. Wank S. A., Pisegna J. R., and de Weerth A. (1992b) Brain and gastrointestinal cholecystokinin receptor family: structure and functional expression. Proc. Natl. Acad. Sci. USA 89, 8691-8695.
42. Wess J., Brann M. R., and Bonner T. I. (1989) Identification of a small intracellular region of the muscarinic m3 receptor as a determinant of selective coupling to PI turnover. FEBS Lett. 258, 133-136.
43. s in response to muscarinic agonists. J. Biol. Chem. 265, 6219-6224.
44. αq/11 mediates cholecystokinin activation of the cationic conductance in rat substantia nigra dopaminergic neurons. J. Neurochem. 66, 1060-1066.
45. Wu T. and Wang H. L. (1996b) The excitatory effect of cholecystokinin on rat neostriatal neurons: ionic and molecular mechanisms. Eur. J. Pharmacol. 307, 125-132.
46. Yokota Y., Sasai Y., Tanaka K., Fugiwara T., Tsuchida K., Shigemoto R., Kakisuka A., Ohkubo H., and Nakanishi S. (1989) Molecular characterization of a functional cDNA for rat substance P receptor. J. Biol. Chem. 264, 17649-17652.
47. You Z. B., Herrera-Marschitz M., Brodin E., Meana J. J., Morino P., Hökfelt T., Silveria R., Goiny M., and Ungerstedt L. (1994) On the origin of striatal cholecystokinin release: studies with in vivo microdialysis. J. Neurochem. 62, 76-86
48. Zhao D., Yang J., Jones K., Gerald C., Susuk, Y., Hogan P., Chin W., and Tashjian A. H. (1992) Molecular cloning of a cDNA encoding the thyrotropin-releasing hormone receptor and regulation of its messenger RNA in rat GH cells. Endocrinology 130, 3529-3536.